Boston Scientific Corp. (NYSE:BSX)

Top Analyst Upgrades and Downgrades: Boston Scientific, Ciena, GoDaddy, Kratos, Lipocine, Repligen, Teladoc and More

Stocks have hit new all-time highs in recent days, and they are indicated to open higher on Friday. The trend that has continued to prevail has been for investors to ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Amazon, Barrick Gold, Boston Scientific, Chipotle, Gap, Gilead, Goldcorp, Workday and More

Stocks set yet another record on the Dow and S&P, but some top chip and tech names have started finding some cracks after massive gains in 2017. The major indexes ...
Read Full Story »

Tuesday’s Biggest Winners and Losers in the S&P 500

November 28, 2017: The S&P 500 closed up 1% at 2,627.20. The DJIA closed up 1.1% at 23,838.64. Separately, the Nasdaq was up 0.5% at 6,912.36. Tuesday was a very ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Boston Scientific, Cleveland-Cliffs, GE, Hasbro, Illumina, T-Mobile, United Continental, Seagate and More

Stocks managed to sell off on Monday after a whole week of hitting higher all-time highs. The Dow Jones Industrial Average was indicated to open over 100 points higher on ...
Read Full Story »

3 Red-Hot Medical Tech Stocks That Could Beat Earnings Estimates

Despite the concerns over the struggles of politicians to craft a new health care plan for the United States, the health care sector, and many of its subsectors, have had ...
Read Full Story »
Microsoft headquarters

Massive Technology Trades Highlight Insider Selling: Apple, Microsoft, Google, Texas Instruments and More

Once again last week the market was hitting all-time highs, and once again insiders were selling shares at a furious pace. Who can blame them? While the outlook for 2017 ...
Read Full Story »
coins

Boston Scientific Remains Flat After Meeting Earnings

When Boston Scientific Corp. (NYSE: BSX) reported its third-quarter earnings results before the markets opened on Wednesday, it said that it had $0.27 in earnings per share (EPS) and $2.11 ...
Read Full Story »
surgery

Why Boston Scientific Shares Could Rise Almost 40% More as Turnaround Continues

Boston Scientific Corp. (NYSE: BSX) was seemingly on the long way down, until 2013 when the stock kicked into gear and became one of the standout turnaround stories. The stock ...
Read Full Story »
bull and bear

Top Analyst Upgrades and Downgrades: Boston Scientific, Micron Tech, Salesforce.com, TransCanada, Walgreens and More

Stocks seem to be on pause and waiting for Friday's payrolls and unemployment report for a last directional change. What has not changed is that investors do not seem to ...
Read Full Story »
medical care

Analysts See Boston Scientific Turnaround Continuing to Run

When Boston Scientific Corp. (NYSE: BSX) reported second-quarter results Wednesday, revenues were up 10% overall, with medical and surgical product sales up 29%. Shares rose nearly 3% on Thursday but ...
Read Full Story »
bull and bear

Top Analyst Upgrades and Downgrades: Alcoa, Boston Scientific, Schlumberger, Sony, Staples and Many More

Stocks were down marginally on Monday morning, but the reality is that the results are so low that no real direction can be determined. The Dow is now down 600 ...
Read Full Story »
Medical interface

Top 4 Medtech Picks From Merrill Lynch

Currently, medical technology, or medtech, is barely outperforming the S&P as health care is struggling despite what is seen as low valuations. Although these valuations are attractive, the backdrop for ...
Read Full Story »
buy button

Massive Biotech Purchases Highlight Insider Buying: Incyte, TransDigm, Prospect Capital, Xenoport and More

Finally, after what seemed like the longest six weeks in history, the market staged at least a solid attempt to rally and restore investor confidence this past week. Firming oil ...
Read Full Story »
Sell Button

Insider Selling Slows Despite Big Market Rally: Boston Scientific, Service Now and More

While the natural inclination is to think that corporate executives and institutions would like to sell stock into a big market rally like the one this past week, the data ...
Read Full Story »

6 BioPharma Movers That Cannot Be Ignored

Last week, a few biotech companies made absolutely massive runs, and some had serious falls. In the past year, the health care sector was on fire from positive trials, U.S. ...
Read Full Story »